Stay updated on Pembrolizumab in Recurrent HNSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent HNSCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0, with no visible changes to study details, eligibility criteria, endpoints, or locations.
    Difference
    0.1%
    Check dated 2026-03-18T17:47:19.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T16:52:01.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now listed, replacing the previous v3.4.1. The site-wide notice about government operating status has been removed.
    Difference
    0.4%
    Check dated 2026-02-11T02:13:48.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A site-wide funding status notice was added, and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:41:48.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page adds a glossary display and updates footer/version text (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0), replacing earlier lowercase variants and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:31:40.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.3.3 to v3.3.4; no visible changes to study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:48:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.